Fudholi, 2007, Studi Pelepasan Invitro Ibuprofenĭari Matriks Xanthan Gum yang Dikombinasikan dengan SuatuĬrosslinking Agent, Majalah Farmasi Indonesia, 18 (3), 133-140. Green, J.M., 1996, A Practical Guide to Analysis Method Validation,23,305-309. Release Mechanisms Behind Polysaccharides-Based FamotidineĬontrolled Release Matrix Tablets, AAPS PharmSciTech, Vol 9, Prespective, International Journal of Health Resesarch,ĭepartemen Kesehatan RI. Khan, 2009, Drug Delivery System : A Patent Systems, Acta Poloniae Pharmaceutica-Drug Researh, 67, 3,ĭehghan, M.H.G., F.N. Modelling on Drug Release from Controlled Drug Delivery In Aulton’s Pharmaceutics : The Design and Manufacture of Medicines, edisi 3, Elsevier, China, 492, 493.ĭash, S., P.N. Moreton, 2009, Modified Release Peroral Dosage Form 2008, Effects of Filler-Binders and Lubricants on Physicochemical Properties of Tablets Obtained by Direct Compression: A 22 Factorial Design, Latinīertuzzi, G., 2005, Effervesent Granulation in Handbook of Pharmaceutical Granulation Technology, Boca Raton, Taylor &īolton, S., 1990, Pharmaceutical Statistics: Practical and clinical applications, 2nd ed., Marcel Dekker, inc., New York.Ĭollett, J.H., R.C. Physicochemical Evaluation of Ranitidine Effervescent Tablets,Īdvanced Pharmaceutical Bulletin, 3(2), 315-322.īanakar, U.V., 1992, Pharmaceutical Dissolution Testing, Marcel Dekkerīastos, M., Friedrich, R.B., Beck, R.C.R. Jahangiri, 2013, Formulation, Characterization and US Pharmacopeial Convention, Rockville, MD,Īnsel, H.C., 1990, Pharmaceutical Dosage Forms and Drug Delivery Systems, 5th ed, London, Pharmaceutical Press.Īrief, M., 1994, Farmasetika, Gajah Mada University Press, Yogyakarta,Īslani, A., H.
Troutman, 2002, Handbook of Clinical Drug Data, 10th ed., McGraw-Hill Companies, NorthĪnonim, 1979, Farmakope Indonesia, ed.III, Departemen Kesehatan RIĪnonim, 2003, Guidelines on Method Validation to be Performed in Support of Analytical Methods for Agrochemical Formulations,Īnonim, 2005, Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series), ColorconĪnonim, 2006, USP29-NF24, General Information Chapter ‘ Healthy Human Subjects Using Two Binders, Bull. Mahmood, 2006, Pharmacokinetic Studies of Ranitidine Tablets in
0 kommentar(er)
